First Time Loading...

IGM Biosciences Inc
NASDAQ:IGMS

Watchlist Manager
IGM Biosciences Inc Logo
IGM Biosciences Inc
NASDAQ:IGMS
Watchlist
Price: 9.48 USD -1.56%
Updated: May 2, 2024
Section:
 

Wall Street
Price Targets

IGMS Price Targets Summary
IGM Biosciences Inc

Wall Street analysts forecast IGMS stock price to rise over the next 12 months.

According to Wall Street analysts, the average 1-year price target for IGMS is 21.65 USD with a low forecast of 12.12 USD and a high forecast of 50.4 USD.

IGMS Lowest Forecast
Wall Street Target
12.12 USD
28% Upside
IGMS Average Forecast
Wall Street Target
21.65 USD
128% Upside
IGMS Highest Forecast
Wall Street Target
50.4 USD
432% Upside
Lowest
Price Target
12.12 USD
28% Upside
Average
Price Target
21.65 USD
128% Upside
Highest
Price Target
50.4 USD
432% Upside
IGM Biosciences Inc Competitors:
Price Targets
BIOPOR
Bioporto A/S
288% Upside
4587
PeptiDream Inc
36% Upside
PANACEABIO
Panacea Biotec Ltd
51% Downside
LYEL
Lyell Immunopharma Inc
163% Upside
BIOPOR
Bioporto A/S
288% Upside
4587
PeptiDream Inc
36% Upside
PANACEABIO
Panacea Biotec Ltd
51% Downside
LYEL
Lyell Immunopharma Inc
163% Upside
VITR
Vitrolife AB
48% Upside
ORGO
Organogenesis Holdings Inc
96% Upside
KRON
Kronos Bio Inc
321% Upside
MRKR
Marker Therapeutics Inc
210% Upside

Revenue
Forecast

Revenue Estimate
IGM Biosciences Inc

The compound annual growth rate of IGM Biosciences Inc's revenue for the next 3 years is 202%.

N/A
Past Growth
202%
Estimated Growth
N/A
Estimates Accuracy
N/A
Average
What are analyst estimates?

Operating Income
Forecast

Operating Income Estimate
IGM Biosciences Inc

N/A
Past Growth
N/A
Estimated Growth
Estimates Accuracy
-3%
Average Miss
What are analyst estimates?

Net Income
Forecast

Net Income Estimate
IGM Biosciences Inc

N/A
Past Growth
N/A
Estimated Growth
Estimates Accuracy
-44%
Average Miss
What are analyst estimates?

See Also

Summary
IGMS intrinsic value, competitors valuation, and company profile.
DCF Valuation
IGMS stock valuation using Discount Cash Flow valuation method.
Relative Valuation
IGMS stock valuation using valuation multiples.
Wall Street Estimates
IGMS price targets and financial estimates made by Wall st analysts.
Profitability Analysis
Detailed analysis of the company's profitability.
Solvency Analysis
Analysis of the financial position and solvency of the company.
Financials
Income Statement, Balance Sheet, Cash Flow Statement.
Discount Rate
IGMS stock discount rate: cost of equity and WACC.
Summary
DCF Valuation
Relative Valuation
Wall Street Estimates
Profitability Analysis
Solvency Analysis
Financials
Discount Rate
Discover More
Why do you have more estimates than other sites?

Our estimates are sourced from the pool of sell-side and buy-side analysts that we have access to. What is available on other sites you are seeing are mostly from the sell-side analysts.

What is IGMS's stock price target?
Price Target
21.65 USD

According to Wall Street analysts, the average 1-year price target for IGMS is 21.65 USD with a low forecast of 12.12 USD and a high forecast of 50.4 USD.

What is IGM Biosciences Inc's Revenue forecast?
Projected CAGR
202%

The compound annual growth rate of IGM Biosciences Inc's revenue for the next 3 years is 202%.

ALPHA SPREAD
Join more than 133,500+ value investors using Alpha Spread
Create a free account
or see our plans & pricing

Company

About Us Careers Pricing Affiliate Program Terms of Service Privacy Policy

Help

What is Intrinsic Value? Help Center Contact Us

Tools

Stock Screener Intrinsic Value Calculator DCF Value Calculator Discount Rate Calculator

Stocks

Most Undervalued Stocks High Profitability Stocks High Solvency Stocks Most Popular Stocks

© 2024 Alpha Spread Limited. All Rights Reserved.

www.alphaspread.com is not operated by a broker, a dealer, or a registered investment adviser. Under no circumstances does any information posted on www.alphaspread.com represent a recommendation to buy or sell a security. The information on this site, and in its related newsletters, is not intended to be, nor does it constitute, investment advice or recommendations. The information on this site is in no way guaranteed for completeness, accuracy or in any other way. In no event shall Alpha Spread Limited be liable to any member, guest or third party for any damages of any kind arising out of the use of any content or other material published or available on www.alphaspread.com, or relating to the use of, or inability to use, www.alphaspread.com or any content, including, without limitation, any investment losses, lost profits, lost opportunity, special, incidental, indirect, consequential or punitive damages. Past performance is a poor indicator of future performance.